nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00203	0.00203	CcSEcCtD
Ceftaroline fosamil—Urticaria—Glipizide—type 2 diabetes mellitus	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Renal failure—Losartan—type 2 diabetes mellitus	0.00201	0.00201	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00201	0.00201	CcSEcCtD
Ceftaroline fosamil—Anaemia—Gliclazide—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.00199	0.00199	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Valsartan—type 2 diabetes mellitus	0.00198	0.00198	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Orlistat—type 2 diabetes mellitus	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00194	0.00194	CcSEcCtD
Ceftaroline fosamil—Rash—Repaglinide—type 2 diabetes mellitus	0.00194	0.00194	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00194	0.00194	CcSEcCtD
Ceftaroline fosamil—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00194	0.00194	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.00194	0.00194	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.00193	0.00193	CcSEcCtD
Ceftaroline fosamil—Headache—Repaglinide—type 2 diabetes mellitus	0.00193	0.00193	CcSEcCtD
Ceftaroline fosamil—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.00192	0.00192	CcSEcCtD
Ceftaroline fosamil—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00191	0.00191	CcSEcCtD
Ceftaroline fosamil—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00189	0.00189	CcSEcCtD
Ceftaroline fosamil—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Metformin—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Metformin—type 2 diabetes mellitus	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Convulsion—Gliclazide—type 2 diabetes mellitus	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Ramipril—type 2 diabetes mellitus	0.00184	0.00184	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Losartan—type 2 diabetes mellitus	0.00184	0.00184	CcSEcCtD
Ceftaroline fosamil—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Nausea—Repaglinide—type 2 diabetes mellitus	0.00183	0.00183	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Erythema—Metformin—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Metformin—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Pruritus—Glipizide—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00177	0.00177	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.00177	0.00177	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Palpitations—Valsartan—type 2 diabetes mellitus	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Palpitations—Orlistat—type 2 diabetes mellitus	0.00173	0.00173	CcSEcCtD
Ceftaroline fosamil—Renal failure—Ramipril—type 2 diabetes mellitus	0.00173	0.00173	CcSEcCtD
Ceftaroline fosamil—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00173	0.00173	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00173	0.00173	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00171	0.00171	CcSEcCtD
Ceftaroline fosamil—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Ceftaroline fosamil—Erythema—Irbesartan—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Ceftaroline fosamil—Convulsion—Orlistat—type 2 diabetes mellitus	0.0017	0.0017	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Ceftaroline fosamil—Dizziness—Glipizide—type 2 diabetes mellitus	0.00168	0.00168	CcSEcCtD
Ceftaroline fosamil—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00168	0.00168	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Losartan—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00165	0.00165	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Vomiting—Glipizide—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Ceftaroline fosamil—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Rash—Glipizide—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Glipizide—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Erythema—Losartan—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Headache—Glipizide—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Ceftaroline fosamil—Palpitations—Metformin—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Ramipril—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Ceftaroline fosamil—Anaemia—Irbesartan—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Urticaria—Glyburide—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Headache—Pioglitazone—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Ceftaroline fosamil—Nausea—Glipizide—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Ceftaroline fosamil—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Ceftaroline fosamil—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Ceftaroline fosamil—Pain—Gliclazide—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Constipation—Gliclazide—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Rash—Glimepiride—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Rash—Sitagliptin—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Headache—Glimepiride—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Headache—Sitagliptin—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Ceftaroline fosamil—Anaemia—Losartan—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Metformin—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Ceftaroline fosamil—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Ceftaroline fosamil—Palpitations—Losartan—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Ceftaroline fosamil—Nausea—Glimepiride—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Ceftaroline fosamil—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Ceftaroline fosamil—Urticaria—Gliclazide—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Pruritus—Glyburide—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Constipation—Valsartan—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Ceftaroline fosamil—Erythema—Ramipril—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Ramipril—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Pain—Orlistat—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Ceftaroline fosamil—Rash—Bromocriptine—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00135	0.00135	CcSEcCtD
Ceftaroline fosamil—Headache—Bromocriptine—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Ceftaroline fosamil—Urticaria—Valsartan—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Urticaria—Orlistat—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Ceftaroline fosamil—Constipation—Metformin—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Ceftaroline fosamil—Vomiting—Glyburide—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Ceftaroline fosamil—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Ceftaroline fosamil—Rash—Glyburide—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Ceftaroline fosamil—Headache—Glyburide—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Ceftaroline fosamil—Palpitations—Ramipril—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Convulsion—Ramipril—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Constipation—Irbesartan—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Pain—Irbesartan—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Urticaria—Metformin—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Nausea—Glyburide—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Ceftaroline fosamil—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Ceftaroline fosamil—Pruritus—Valsartan—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Ceftaroline fosamil—Pruritus—Orlistat—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Ceftaroline fosamil—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Ceftaroline fosamil—Pain—Losartan—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Ceftaroline fosamil—Constipation—Losartan—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Ceftaroline fosamil—Rash—Gliclazide—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Ceftaroline fosamil—Urticaria—Irbesartan—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Headache—Gliclazide—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Ceftaroline fosamil—Dizziness—Valsartan—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Ceftaroline fosamil—Dizziness—Orlistat—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Nausea—Gliclazide—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Ceftaroline fosamil—Pruritus—Metformin—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Ceftaroline fosamil—Urticaria—Losartan—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Ceftaroline fosamil—Vomiting—Valsartan—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Rash—Valsartan—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Vomiting—Orlistat—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Headache—Valsartan—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Ceftaroline fosamil—Rash—Orlistat—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Ceftaroline fosamil—Headache—Orlistat—type 2 diabetes mellitus	0.001	0.001	CcSEcCtD
Ceftaroline fosamil—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000983	0.000983	CcSEcCtD
Ceftaroline fosamil—Dizziness—Metformin—type 2 diabetes mellitus	0.000973	0.000973	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000968	0.000968	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000963	0.000963	CcSEcCtD
Ceftaroline fosamil—Nausea—Valsartan—type 2 diabetes mellitus	0.00096	0.00096	CcSEcCtD
Ceftaroline fosamil—Constipation—Ramipril—type 2 diabetes mellitus	0.000959	0.000959	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00095	0.00095	CcSEcCtD
Ceftaroline fosamil—Nausea—Orlistat—type 2 diabetes mellitus	0.000949	0.000949	CcSEcCtD
Ceftaroline fosamil—Vomiting—Metformin—type 2 diabetes mellitus	0.000936	0.000936	CcSEcCtD
Ceftaroline fosamil—Rash—Metformin—type 2 diabetes mellitus	0.000928	0.000928	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Metformin—type 2 diabetes mellitus	0.000927	0.000927	CcSEcCtD
Ceftaroline fosamil—Pruritus—Losartan—type 2 diabetes mellitus	0.000925	0.000925	CcSEcCtD
Ceftaroline fosamil—Headache—Metformin—type 2 diabetes mellitus	0.000922	0.000922	CcSEcCtD
Ceftaroline fosamil—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000919	0.000919	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000917	0.000917	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000894	0.000894	CcSEcCtD
Ceftaroline fosamil—Urticaria—Ramipril—type 2 diabetes mellitus	0.000891	0.000891	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000886	0.000886	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000886	0.000886	CcSEcCtD
Ceftaroline fosamil—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000883	0.000883	CcSEcCtD
Ceftaroline fosamil—Rash—Irbesartan—type 2 diabetes mellitus	0.000876	0.000876	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000875	0.000875	CcSEcCtD
Ceftaroline fosamil—Nausea—Metformin—type 2 diabetes mellitus	0.000874	0.000874	CcSEcCtD
Ceftaroline fosamil—Headache—Irbesartan—type 2 diabetes mellitus	0.00087	0.00087	CcSEcCtD
Ceftaroline fosamil—Dizziness—Losartan—type 2 diabetes mellitus	0.000865	0.000865	CcSEcCtD
Ceftaroline fosamil—Vomiting—Losartan—type 2 diabetes mellitus	0.000831	0.000831	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000826	0.000826	CcSEcCtD
Ceftaroline fosamil—Nausea—Irbesartan—type 2 diabetes mellitus	0.000825	0.000825	CcSEcCtD
Ceftaroline fosamil—Rash—Losartan—type 2 diabetes mellitus	0.000824	0.000824	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Losartan—type 2 diabetes mellitus	0.000824	0.000824	CcSEcCtD
Ceftaroline fosamil—Headache—Losartan—type 2 diabetes mellitus	0.000819	0.000819	CcSEcCtD
Ceftaroline fosamil—Pruritus—Ramipril—type 2 diabetes mellitus	0.000793	0.000793	CcSEcCtD
Ceftaroline fosamil—Nausea—Losartan—type 2 diabetes mellitus	0.000777	0.000777	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000767	0.000767	CcSEcCtD
Ceftaroline fosamil—Dizziness—Ramipril—type 2 diabetes mellitus	0.000741	0.000741	CcSEcCtD
Ceftaroline fosamil—Vomiting—Ramipril—type 2 diabetes mellitus	0.000713	0.000713	CcSEcCtD
Ceftaroline fosamil—Rash—Ramipril—type 2 diabetes mellitus	0.000707	0.000707	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000706	0.000706	CcSEcCtD
Ceftaroline fosamil—Headache—Ramipril—type 2 diabetes mellitus	0.000702	0.000702	CcSEcCtD
Ceftaroline fosamil—Nausea—Ramipril—type 2 diabetes mellitus	0.000666	0.000666	CcSEcCtD
